VIRA Stock UPDATES Viratech Corp (VIRA) 0.0027 09/10/2014 21

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Viratech Corp (VIRA) 0.0027 $VIRA

BUYINS.NET Issues Viratech Corp. SqueezeTrigger Report
GlobeNewswire - Tue Jul 16, 7:30AM CDT
-- Approximately 600,187 Shares Shorted Since May 2013

Viratech Corp. Publishes e-Book on Open Source Biotech Research
Marketwire - Wed Feb 27, 8:02AM CST
Viratech Corp. (PINKSHEETS: VIRA), the first open source biotech research social network platform, announced today that it has published its e-Book on open source biotech research. The book, "Open Source Cancer Research," by Dr. Kevin Buckman, describes how the first open source biotech research social network platform works to make it possible for individuals or smaller companies to compete with larger companies in the race to patent new medicines or technology. The book can be purchased at: http://www.amazon.com/Open-Source-Cancer-Rese...B00BL8N3TA.

Viratech and Diabetes.net Sign Agreement
Marketwire - Thu Feb 21, 8:01AM CST
Viratech Corp. (PINKSHEETS: VIRA), the first open source biotech research social network platform, announced today that it has entered into a letter of intent to provide a turn-key Social Network for Diabetes Network Charities at http//diabetes.net, for $250,000, plus 25% royalty from all revenue derived from the operation of the site.

Viratech Corp. Launches Cancer.im Cancer Patient Support Social Network
Marketwire - Mon Feb 18, 11:01PM CST
Viratech Corp. (PINKSHEETS: VIRA), the first open source biotech research social network platform, announced today the launch of Cancer.im, http://cancer.im, a social network resource site for cancer patients, survivors, advocates, and volunteers. Cancer.im harnesses social collaboration utilities to develop what Viratech believes will become the first experience-based search engine powered by social collaboration http://www.youtube.com/watch?v=dz1tHRb3wvU.

Harbinger Issues Special Situation Report on Viratech Corp.
Marketwire - Mon Jan 28, 8:02AM CST
Harbinger Research is pleased to announce the issuance of a Special Situations report pertaining to Viratech Corporation, (PINKSHEETS: VIRA). http://www.harbingerresearch.com/clients/vira

Breast Cancer Book Achieves Number 1 Best Seller Status on Amazon.com
Marketwire - Sun Jan 27, 4:51PM CST
Viratech Corp. (PINKSHEETS: VIRA) announced today that Cancer.im's first of 235 books to be released on Amazon's Kindle platform, focusing on Cancer, Find and Stop Breast Cancer, by Dr. Kevin Buckman, has achieved number 1 best-seller status for both Breast Cancer and Oncology categories. The book can be bought here: http://www.amazon.com/Find-Stop-Breast-Cancer...ast+cancer

Cancer.im Announces Breast Cancer Book Released via Amazon's Kindle Platform
Marketwire - Thu Jan 24, 9:41AM CST
Viratech Corp. (PINKSHEETS: VIRA) announced today that Cancer.im, http://www.Cancer.im, designed to be the world's first experience based social network resource site for people affected by cancer, has released the first of 235 books to be released on Amazon's Kindle platform, focusing on Cancer.

Viratech Signs Letter of Intent to Provide Social Network for $250,000, Royalties and Equity Interest
Marketwire - Fri Jan 18, 8:00AM CST
Viratech Corp. (PINKSHEETS: VIRA), the first open source biotech research social network platform, announced today that it has entered into a letter of intent to provide a turnkey Social Network for Wellness Builder, Inc., a company engaged in the development of a series of nutraceutical products designed to combat the effects of stress, inadequate nutrition and exposure to environmental toxins.

Dr. Mort Rothbard Joins Viratech Advisory Board
Marketwire - Tue Jan 08, 9:38AM CST
Viratech Corp. (PINKSHEETS: VIRA), the first open source biotech research social network platform, announced today the addition of Mort Rothbard MD to its Advisory Board.

Viratech Announces Acquisition of Cancer.im for $6.2 Million in Securities
Marketwire - Thu Dec 20, 5:58AM CST
Viratech Corp. (PINKSHEETS: VIRA) http://viratech.org, the first open source biotech research social network platform, announced today an acquisition merger with Cancer.im, Inc., in exchange for $6.2 million in Viratech restricted common stock.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Infrared Imaging Expands with AI, SWIR: Tech Trends

Updated Category News Views 5

Infrared Imaging: The Backbone of Future Tech Kinda wild how infrared imaging's become a hot topic in tech circles. With the market expected to jump from USD 9.2 billion in 2026 to a hefty USD 12.6 billion by 2031, averaging a 6.4% growth rate, there's plenty to chew on. Even if you ain't the analytical type, it ain't hard to spot where the money's flowing. Infrared's...

Continue Reading
PostalAnnex Lands at Stanford with New Service Hub

Updated Category News Views 2

PostalAnnex Makes a Strategic Stanford Move It's not every day you see a company nestling into a place like Stanford University. Annex Brands has just opened its latest PostalAnnex location, a stone’s throw from the academic hustle and bustle of the Stanford campus. The geeky vibe of students and professors rushing with deadlines matches well with the efficient service...

Continue Reading
Mattamy Homes Earns Spot as Top Workplace in Jacksonville

Updated Category News Views 8

Jacksonville's Housing Scene Gets a Boost In a world where everyone seems bent on working down to the bone to climb some imaginary corporate ladder, here comes Jacksonville's own Mattamy Homes with a news flash—it's possible to work, live, and still smile at the end of the day. Recently, they earned themselves a coveted spot among the best workplaces in Jacksonville for...

Continue Reading
Retirement Security Faces Global Headwinds in 2026

Updated Category News Views 2

Grappling with an Uncertain Retirement Future Welcome to the 2026 Global Retirement Index (GRI), where it seems we're all being told to brace for a rough retirement ride. This year's results, crafted by Natixis Investment Managers and their pals at CoreData Research, spotlight just how shaky the ground has gotten. The core troublemakers? Aging populations, whopping public...

Continue Reading
Clarius Named in TIME's Top HealthTech 2026 Again

Updated Category News Views 2

When a company gets the nod from TIME two years in a row, you know they’re not just tinkering with gadgets—they’re changing the game. Clarius Mobile Health, with its cutting-edge wireless ultrasound tech, has cemented its place in TIME's World's Top HealthTech Companies of 2026. Last I checked, repeating this kind of recognition never comes easy in such a fiercely...

Continue Reading
Key Insights for Launching a Mobile Grooming Biz

Updated Category News Views 4

Riding the Mobile Revolution with Grooming Anyone who's dabbled in grooming knows that moving to a mobile setup isn’t just about freedom and flexibility—it's a whole new ballgame. We're talking Chris Hanvey-level insights here, direct from Easley, S.C. This ain't your average jump in a van and snip some fur operation. Choosing the Right Rig First on the list: the...

Continue Reading
Miguel Pantoja: Wiring a Second Chance Beyond Bars

Updated Category News Views 2

A Second Shot with Electric Dreams Miguel Pantoja, once on the rocky road of life choices, now lights up Northern California with his spark — quite literally. Walking out of federal prison, his mind was set as firmly as a bolt: first stop was a burger, second was a plan to transform his past into a new beginning. That path took him to UEI College in Sacramento, where...

Continue Reading
Quantum Sky's Strategic Leadership Overhaul Targets Growth

Updated Category News Views 3

Executive Shake-Up Aims for Stronger Federal Market Alignment Buckle up, folks—there's some major chess-piecing happening at Quantum Sky. They've just named not one or two, but three executive bigwigs to head up their core business groups. This isn’t just some ceremonial reshuffle. Nah, it’s bigger. They're redefining how they tackle the Department of War, Intel &...

Continue Reading
AMD CEO, Global Leaders Converge At IMPERIA Summit

Updated Category News Views 3

A Clash of Giants in New York The trade floors are buzzing in New York as the world's economic heavyweights and tech titans gather for the inaugural IMPERIA Summit. You can almost smell the pressure and ambition wafting through the streets when folks like AMD's CEO, Lisa Su, share the stage with geopolitical power players like President Trump and China's President Xi...

Continue Reading
Synopsys-TSMC Collaboration Drives AI System Evolution

Updated Category News Views 4

Synopsys and TSMC: The New Power Couple in AI Ah, the world of semiconductors—where the chips are small but the stakes are colossal. Once again, Synopsys and TSMC have thrown their hats into the ring, diving headfirst into yet another ambitious collaboration. Their latest mission? To fast-track the evolution of AI systems through a suite of innovations strapped to...

Continue Reading

Top 5 Most Recently Viewed Articles

Galaxy Digital Reports Impressive Q3 Financial Growth

Updated Category News Views 152

Galaxy Digital Inc. Financial Highlights for Q3 2025 Galaxy Digital Inc. (NASDAQ: GLXY) has once again demonstrated its formidable presence in the financial and digital asset landscape with remarkable results for the third quarter of 2025. The company reported a net income of $505 million, equating to a diluted earnings per share (EPS) of $1.01, and an adjusted EPS of...

Continue Reading
Key Insights on Top Performing Stocks in Today's Market

Updated Category News Views 351

Market Performance Overview The stock market saw a positive trend recently, with key indexes showing notable gains. The Dow Jones Industrial Average increased by 0.6%, closing at 42,175.11, while the S&P 500 added 0.4% to end at 5,745.37. Additionally, the Nasdaq climbed 0.6%, reaching a closing value of 18,190.29. This momentum reflects growing optimism among investors,...

Continue Reading
Auris Medical Holdings Faces Challenges as CYTO Hits New Lows

Updated Category News Views 46

Market Challenges Leading to CYTO's Decline In today's volatile market, Auris Medical Holding's stock, CYTO, has reached a concerning 52-week low of $0.57. This downward trajectory paints a troubling picture for investors, as the stock has plummeted by 82.67% over the past year, highlighting the challenges that the company is currently facing. Investor Concerns Amid...

Continue Reading
Mount Logan Capital's 2025 Q3 Results Show Significant Growth

Updated Category News Views 196

Mount Logan Capital Inc. Reveals Impressive Third Quarter Performance Mount Logan Capital Inc. (NASDAQ: MLCI) recently released its financial results for the third quarter, showcasing remarkable growth and stability in the company’s operations. Key Achievements in Q3 2025 The company declared a quarterly distribution of $0.03 per common share, marking its inaugural...

Continue Reading
Agilon Health, Inc. Under Scrutiny for Possible Violations

Updated Category News Views 139

Understanding Agilon Health's Situation The legal landscape is always evolving, and companies must navigate a range of potential challenges. Agilon Health, Inc. is currently in the spotlight due to an investigation led by a nationally recognized law firm. This investigation aims to assess whether Agilon has breached federal securities laws, along with examining its...

Continue Reading